Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non–small cell lung cancer

B Li, Y Cui, M Diehn, R Li - JAMA oncology, 2017 - jamanetwork.com
… on gene expression–based prognostic signatures 6 -10 has … , we developed a prognostic
signature based on 25 immune-… Our prognostic immune signature can further stratify clinically …

Exploration of the molecular characteristics of the tumor–immune interaction and the development of an individualized immune prognostic signature for …

W Jin, Y Zhang, Z Liu, Z Che, M Gao… - Journal of Cellular …, 2021 - Wiley Online Library
individualized immune gene-associated prognosis signature that was reliable and independent
of other factors and showed more favorable potential for the prediction of the prognosis

Identification and validation of an individualized prognostic signature of bladder cancer based on seven immune related genes

H Qiu, X Hu, C He, B Yu, Y Li, J Li - Frontiers in genetics, 2020 - frontiersin.org
… of prognostic signature based on immune-related genes (IRGs). This study aimed to develop
an IRG-based prognostic signature … Among these genes, prognostic IRGs were identified …

An individualized immune prognostic signature in lung adenocarcinoma

L Sun, G Jiang, D Gonzalez-Rivas, P Zhang - Cancer Cell International, 2020 - Springer
… In this study, we developed an immune prognostic signature based on the 6 leukocytes
and validated it in two independent datasets from different platforms. The results showed a …

Individualized immune-related gene signature predicts immune status and oncologic outcomes in clear cell renal cell carcinoma patients

Y Xiong, L Liu, Q Bai, Y Xia, Y Qu, J Wang… - … Oncology: Seminars and …, 2020 - Elsevier
… in prognosis evaluation of cancer [10]. In this study, we developed and validated a personalized
immune-related gene signature … The prognostic gene signature showed comparable …

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

S Shen, G Wang, R Zhang, Y Zhao, H Yu, Y Wei… - …, 2019 - thelancet.com
… We aim to develop a generalized, individualized immune prognostic signature that can …
step, we develop a prognostic signature named the immune-based prognostic signature for OV (…

Development and validation of an individualized immune prognostic signature for recurrent prostate cancer

Y Jin, L Wang, H Lou, C Song, X He… - … Chemistry & High …, 2021 - ingentaconnect.com
… : Background: Immune-related genes possess promising prognostic potential in multiple
cancer types. Here, we describe the development of an immune-related prognostic signature for …

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma

QF Yang, D Wu, J Wang, L Ba, C Tian, YT Liu, Y Hu… - Scientific Reports, 2021 - nature.com
… We developed a prognostic signature from immune-related genes (IRGs) derived from the
ImmPort database 24 . First, identification of differentially expressed IRGs between LUSC and …

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Q Song, J Shang, Z Yang, L Zhang, C Zhang… - Journal of translational …, 2019 - Springer
prognostic signature on the basis of TIM in TCGA dataset and proved its efficacy in four GEO
datasets. Our signature … of patients’ OS, individualized therapy methods based on the risk …

Mechanistically derived patient-level framework for precision medicine identifies a personalized immune prognostic signature in high-grade serous ovarian cancer

H Zhao, S Gu, S Bao, C Yan, Z Zhang… - Briefings in …, 2021 - academic.oup.com
… a patient-level computational framework to identify and validate an individualized gene
signature from mechanistic and translational perspectives, which could effectively predict …